Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Cancer Research UK 


We’re the largest charitable funder of cancer research in the world, funding around 50% of all publicly funded cancer research here in the UK. We’re working every day to find new and improved ways to prevent, diagnose and treat cancer, to make it a disease people no longer die from.

Great researchers are at the heart of world-class cancer research. We play a vital role in attracting and developing the cancer researchers of the future and ensuring effective leadership. We work with the best scientists and partner organisations across the globe to beat cancer.
Cancer Research UK’s world-class research network provides the foundations for scientists to carry out research, ranging from fundamental laboratory studies to large-scale clinical trials. Through collaboration across the different research sites, we are bringing benefits to people with cancer faster.


About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With approximately 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE.

Drawing on more than 45 years of experience, ESMO serves its members and the oncology community by:

  • providing networking and professional growth opportunities: through ESMO, oncologists can engage in projects, committees and working groups aiming to promote science and foster improvements in the oncology practice;
  • providing training, resources and tools which enable oncologists to stay up-to-date with the latest scientific advances and continue to deliver the best possible care to cancer patients;
  • representing and advocating for the oncology community at the highest political levels, ensuring that the needs of both patients and doctors are properly taken care of.

Cancer care becomes more integrated and more specialised every day; whether their field is research, diagnosis, treatment, care, or advocacy, oncology professionals need to both build their specialist knowledge and connect with the best practitioners in other disciplines worldwide. ESMO membership makes this possible.



Unicancer is the only French hospital federation 100% dedicated to the fight against cancer. Through its health cooperation group, Unicancer is also the only national hospital network exclusively specialised in oncology. It brings together 18 French Comprehensive Cancer Centres (FCCCs) and two affiliated members, representing more than 21,000 employees committed to a permanent quest for excellence in care, research and continuing professional education. Exclusively dedicated to the fight against cancer, all the private non-profit centres in the Unicancer network operate on a fully public basis and play a major role at the forefront of therapeutic, scientific and organisational innovation.
Research is at the heart of Unicancer: clinical, translational and health data research. Rigorous and relevant, it aims to put innovation at the service of the patient. Unicancer is the first academic sponsor of clinical trials in oncology in Europe – our R&D department directly works with the research units of FCCCs and other health institutions in France and abroad – and a recognised leader in the field of research, both in terms of Unicancer’s R&D department and the R&D departments of each individual centre. The Unicancer network is world-renowned and more than 15% of patients in French comprehensive cancer centres are included in clinical trials, compared to 8.5% on average in French health care facilities. In each of our centres, multidisciplinary teams associate care and research units to develop integrated cancer research.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.